sdz 51641 has been researched along with Alloxan Diabetes in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (66.67) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aicher, TD; Bebernitz, GR; Bell, PA; Brand, LJ; Dain, JG; Deems, R; Fillers, WS; Foley, JE; Knorr, DC; Nadelson, J; Otero, DA; Simpson, R; Strohschein, RJ; Young, DA | 1 |
| Bebernitz, GR; Dain, JG; Deems, RO; Otero, DA; Simpson, WR; Strohschein, RJ | 1 |
| Bell, PA; Cohen, DK; Foley, JE; Ho, RS; McIntosh, RH; Nadelson, J; Young, DA | 1 |
3 other study(ies) available for sdz 51641 and Alloxan Diabetes
| Article | Year |
|---|---|
Hypoglycemic prodrugs of 4-(2,2-dimethyl-1-oxopropyl)benzoic acid.
Topics: Acetophenones; Animals; Benzoates; Diabetes Mellitus, Experimental; Drug Evaluation, Preclinical; Fatty Acids; Gluconeogenesis; Hypoglycemic Agents; In Vitro Techniques; Liver; Male; Oxidation-Reduction; Prodrugs; Rats; Rats, Sprague-Dawley; Stereoisomerism; Structure-Activity Relationship; Testis | 1999 |
Reduction in glucose levels in STZ diabetic rats by 4-(2,2-dimethyl-1-oxopropyl)benzoic acid: a prodrug approach for targeting the liver.
Topics: Animals; Area Under Curve; Benzoates; Blood Glucose; Diabetes Mellitus, Experimental; Fatty Acids; Hepatocytes; Hypoglycemic Agents; In Vitro Techniques; Liver; Male; Oxidation-Reduction; Prodrugs; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship | 2001 |
Inhibition of hepatic glucose production by SDZ 51641.
Topics: Administration, Oral; Animals; Cholesterol; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 2; Dioxolanes; Disease Models, Animal; Fatty Acids; Glucose; Hypoglycemic Agents; Ketones; Liver; Male; Oxidation-Reduction; Rats; Rats, Inbred Strains; Triglycerides | 1990 |